REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Interest Expense in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q1 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.49K, a 54.4% decline year-over-year.
  • Reviva Pharmaceuticals Holdings, Inc. annual Interest Expense for 2021 was $0.000, a 100% decline from 2020.
  • Reviva Pharmaceuticals Holdings, Inc. annual Interest Expense for 2020 was $1.45M, a 210% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.49K -$4.17K -54.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $5.9K +$5.9K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $12.8K +$12.8K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.66K +$7.66K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $0 -$146K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $0 -$99.1K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q4 2020 $1.45M $1.08M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $146K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $99.1K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $130K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.